BSEBandaram Pharma Packtech Ltd· Healthcare ServicesHighNegative
Announced Fri, 5 Jun, 2026 · 17:21 IST

Resignation of Whole-Time Director of the Company.

Kmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.0%Reaction day
₹28.87
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.0%-1.1% vs market
Healthcare Service Provider peers, median of 25sector-1.1%-2.0% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.0-2.0-1.1-1.1-2.0
Next day
-3.0-0.1-2.9-1.6-1.4
2d
-2.7-1.6-1.1-3.1+0.4
3d
-0.1-2.7+2.6-2.7+2.6
4d
-4.5+0.3-4.8-1.6-2.9
5d
-3.0+2.0-5.0-1.6-1.4
1w
+1.5+3.7-2.2+0.9+0.6
15d
+6.1+5.2+0.9+0.2+5.9
1m
-23.4+3.3-26.8-1.9-21.6
2m
-32.5+9.0-41.5-1.8-30.7
3m
-24.8+11.8-36.6-0.6-24.2
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. NSK Aakarsh Raj (DIN: 09530950) has resigned from the position of Whole-Time Director of Bandaram Pharma Packtech Ltd, effective 5 June 2026, citing other professional and personal reasons. The company confirmed there are no material reasons for the resignation beyond what was stated. The disclosure has been made to BSE under SEBI LODR Regulations. Deepak Bandaram continues as Chairman and Managing Director. No replacement appointment has been announced in this filing.

Likely market impact

The exit of a whole-time director may create a short-term governance gap, but no adverse reasons were cited. Investors should watch for any subsequent announcement on a replacement, as prolonged vacancy could affect operational continuity.